ANBP2 randomized hypertensive patients to initial treatment with an ACE inhibitor (n = 3044) or a diuretic (n = 3039).
Thus ANBP2 actually confirms the results from ALLHAT by showing that ACE inhibitors and diuretics are equivalent in reducing cardiovascular events in hypertension.
(4-8,10,11,13-17) Of the remaining 2 trials, the difference in ANBP2 just reached a P value of .05, while the result in LIFE was driven by a lower stroke incidence on ARB treatment that is not noted in any of the other studies involving an ARB or ACE inhibitor.